ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dry Powder Inhaler Device Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-1J368
Home | Market Reports | Health| Medical Devices & Equipment
Global Dry Powder Inhaler Device Market Insights and Forecast to 2028
BUY CHAPTERS

Global Dry Powder Inhaler Device Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-1J368
Report
June 2025
Pages:157
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Boehringer Ingelheim
Chiesi
Cipla Ltd
3M
Hovione
Mannkind
Novartis
Schering/Merck
TEVA
Vectura
GlaxoSmithKline
GlaxoSmithKline PLC
Astrazeneca plc
Mylan NV

Dry Powder Inhaler Device Market Size

In 2024, the global market size of Dry Powder Inhaler Device was estimated to be worth US$ 865 million and is forecast to reach approximately US$ 1203 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.

Dry Powder Inhaler Device Market

Dry Powder Inhaler Device Market

A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.
GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, etc. are the key players in the global Dry Powder Inhaler Device market. Top 4 took up more than 30% of the global market.
From the view of region, USA have a larger consumption market share which account for about 35% of total share. Europe hold a market share of about 25%. In addition, Asia Pacific is also play important role in Global market.
Dry Powder Inhaler Device main application area is Asthma This sector hold a market share of over 80%. Then followed by the COPD.
According to the Segmentation of types, all the market of Dry Powder Inhaler Device can be divided as follows: Multi-dose, Single-dose.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dry Powder Inhaler Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Powder Inhaler Device.
The Dry Powder Inhaler Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dry Powder Inhaler Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dry Powder Inhaler Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Dry Powder Inhaler Device Market Report

Report Metric Details
Report Name Dry Powder Inhaler Device Market
Forecasted market size in 2031 approximately US$ 1203 million
CAGR 4.9%
Forecasted years 2025 - 2031
Segment by Type
  • Single Dose
  • Multi Dose
Segment by Application
  • Asthma
  • COPD
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind, Mylan, Novartis, Schering/Merck, Teva, Vectura
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Dry Powder Inhaler Device in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Dry Powder Inhaler Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dry Powder Inhaler Device sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Dry Powder Inhaler Device Market size in 2031?

Ans: The Dry Powder Inhaler Device Market size in 2031 will be approximately US$ 1203 million.

What is the Dry Powder Inhaler Device Market share by region?

Ans: From the view of region, USA have a larger consumption market share which account for about 35% of total share. Europe hold a market share of about 25%.

What is the Dry Powder Inhaler Device Market share by application?

Ans: Dry Powder Inhaler Device main application area is Asthma This sector hold a market share of over 80%.

Who are the main players in the Dry Powder Inhaler Device Market report?

Ans: The main players in the Dry Powder Inhaler Device Market are GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind, Mylan, Novartis, Schering/Merck, Teva, Vectura

What are the Application segmentation covered in the Dry Powder Inhaler Device Market report?

Ans: The Applications covered in the Dry Powder Inhaler Device Market report are Asthma, COPD, Others

What are the Type segmentation covered in the Dry Powder Inhaler Device Market report?

Ans: The Types covered in the Dry Powder Inhaler Device Market report are Single Dose, Multi Dose

1 Study Coverage
1.1 Dry Powder Inhaler Device Product Introduction
1.2 Market by Type
1.2.1 Global Dry Powder Inhaler Device Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Single Dose
1.2.3 Multi Dose
1.3 Market by Application
1.3.1 Global Dry Powder Inhaler Device Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Asthma
1.3.3 COPD
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dry Powder Inhaler Device Market Size Estimates and Forecasts
2.1.1 Global Dry Powder Inhaler Device Revenue 2020-2031
2.1.2 Global Dry Powder Inhaler Device Sales 2020-2031
2.2 Dry Powder Inhaler Device Market Size by Region: 2024 Versus 2031
2.3 Dry Powder Inhaler Device Sales by Region (2020-2031)
2.3.1 Global Dry Powder Inhaler Device Sales by Region: 2020-2025
2.3.2 Global Dry Powder Inhaler Device Sales Forecast by Region (2026-2031)
2.3.3 Global Dry Powder Inhaler Device Sales Market Share by Region (2020-2031)
2.4 Dry Powder Inhaler Device Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Dry Powder Inhaler Device Revenue by Region: 2020-2025
2.4.2 Global Dry Powder Inhaler Device Revenue Forecast by Region (2026-2031)
2.4.3 Global Dry Powder Inhaler Device Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Dry Powder Inhaler Device Sales by Type (2020-2031)
3.1.1.1 Global Dry Powder Inhaler Device Sales Volume by Type (2020-2031)
3.1.1.2 Global Dry Powder Inhaler Device Sales Market Share by Type (2020-2031)
3.1.2 Global Dry Powder Inhaler Device Revenue by Type (2020-2031)
3.1.2.1 Global Dry Powder Inhaler Device Revenue by Type (2020-2031)
3.1.2.2 Global Dry Powder Inhaler Device Revenue Market Share by Type (2020-2031)
3.1.3 Dry Powder Inhaler Device Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Dry Powder Inhaler Device Sales by Application (2020-2031)
3.2.1.1 Global Dry Powder Inhaler Device Sales Volume by Application (2020-2031)
3.2.1.2 Global Dry Powder Inhaler Device Sales Market Share by Application (2020-2031)
3.2.2 Global Dry Powder Inhaler Device Revenue by Application (2020-2031)
3.2.2.1 Global Dry Powder Inhaler Device Revenue by Application (2020-2031)
3.2.2.2 Global Dry Powder Inhaler Device Revenue Market Share by Application (2020-2031)
3.2.3 Dry Powder Inhaler Device Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Single Dose of Dry Powder Inhaler Device Revenue Market Share by Application
3.3.2 Multi Dose of Dry Powder Inhaler Device Revenue Market Share by Application
4 Global Dry Powder Inhaler Device by Manufacturers
4.1 Global Top Dry Powder Inhaler Device Manufacturers by Sales (2020-2025)
4.1.1 Global Dry Powder Inhaler Device Sales by Manufacturer (2020-2025)
4.1.2 Global Dry Powder Inhaler Device Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Dry Powder Inhaler Device Manufacturers by Revenue (2020-2025)
4.2.1 Global Dry Powder Inhaler Device Revenue by Manufacturer (2020-2025)
4.2.2 Global Dry Powder Inhaler Device Revenue Share by Manufacturer (2020-2025)
4.3 Global Dry Powder Inhaler Device Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Dry Powder Inhaler Device Manufacturers Covered: Ranking by Revenue
4.4.2 Global Dry Powder Inhaler Device Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Dry Powder Inhaler Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Dry Powder Inhaler Device Manufacturing Base Distribution, Product Type
4.5.1 Dry Powder Inhaler Device Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Dry Powder Inhaler Device Market
4.5.3 Manufacturers Dry Powder Inhaler Device Product Type and Application
4.5.4 Single Dose Market Sales of Dry Powder Inhaler Device by Manufacturer
4.5.5 Multi Dose Market Sales of Dry Powder Inhaler Device by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 GlaxoSmithKline
5.1.1 GlaxoSmithKline Company Information
5.1.2 GlaxoSmithKline Description, Business Overview
5.1.3 GlaxoSmithKline Dry Powder Inhaler Device Products Offered
5.1.4 GlaxoSmithKline Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2020-2025)
5.1.5 GlaxoSmithKline Dry Powder Inhaler Device Sales by Product in 2024
5.1.6 GlaxoSmithKline Dry Powder Inhaler Device Sales by Application in 2024
5.1.7 GlaxoSmithKline Dry Powder Inhaler Device Sales by Geographic Area in 2024
5.1.8 GlaxoSmithKline Recent Developments
5.2 AstraZeneca
5.2.1 AstraZeneca Company Information
5.2.2 AstraZeneca Description, Business Overview
5.2.3 AstraZeneca Dry Powder Inhaler Device Products Offered
5.2.4 AstraZeneca Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2020-2025)
5.2.5 AstraZeneca Dry Powder Inhaler Device Sales by Product in 2024
5.2.6 AstraZeneca Dry Powder Inhaler Device Sales by Application in 2024
5.2.7 AstraZeneca Dry Powder Inhaler Device Sales by Geographic Area in 2024
5.2.8 AstraZeneca Recent Developments
5.3 Boehringer Ingelheim
5.3.1 Boehringer Ingelheim Company Information
5.3.2 Boehringer Ingelheim Description, Business Overview
5.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Products Offered
5.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Boehringer Ingelheim Dry Powder Inhaler Device Sales by Product in 2024
5.3.6 Boehringer Ingelheim Dry Powder Inhaler Device Sales by Application in 2024
5.3.7 Boehringer Ingelheim Dry Powder Inhaler Device Sales by Geographic Area in 2024
5.3.8 Boehringer Ingelheim Recent Developments
5.4 Chiesi
5.4.1 Chiesi Company Information
5.4.2 Chiesi Description, Business Overview
5.4.3 Chiesi Dry Powder Inhaler Device Products Offered
5.4.4 Chiesi Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Chiesi Dry Powder Inhaler Device Sales by Product in 2024
5.4.6 Chiesi Dry Powder Inhaler Device Sales by Application in 2024
5.4.7 Chiesi Dry Powder Inhaler Device Sales by Geographic Area in 2024
5.4.8 Chiesi Recent Developments
5.5 Cipla
5.5.1 Cipla Company Information
5.5.2 Cipla Description, Business Overview
5.5.3 Cipla Dry Powder Inhaler Device Products Offered
5.5.4 Cipla Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Cipla Dry Powder Inhaler Device Sales by Product in 2024
5.5.6 Cipla Dry Powder Inhaler Device Sales by Application in 2024
5.5.7 Cipla Dry Powder Inhaler Device Sales by Geographic Area in 2024
5.5.8 Cipla Recent Developments
5.6 3M
5.6.1 3M Company Information
5.6.2 3M Description, Business Overview
5.6.3 3M Dry Powder Inhaler Device Products Offered
5.6.4 3M Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2020-2025)
5.6.5 3M Dry Powder Inhaler Device Sales by Product in 2024
5.6.6 3M Dry Powder Inhaler Device Sales by Application in 2024
5.6.7 3M Dry Powder Inhaler Device Sales by Geographic Area in 2024
5.6.8 3M Recent Developments
5.7 Hovione
5.7.1 Hovione Company Information
5.7.2 Hovione Description, Business Overview
5.7.3 Hovione Dry Powder Inhaler Device Products Offered
5.7.4 Hovione Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Hovione Dry Powder Inhaler Device Sales by Product in 2024
5.7.6 Hovione Dry Powder Inhaler Device Sales by Application in 2024
5.7.7 Hovione Dry Powder Inhaler Device Sales by Geographic Area in 2024
5.7.8 Hovione Recent Developments
5.8 Mannkind
5.8.1 Mannkind Company Information
5.8.2 Mannkind Description, Business Overview
5.8.3 Mannkind Dry Powder Inhaler Device Products Offered
5.8.4 Mannkind Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Mannkind Dry Powder Inhaler Device Sales by Product in 2024
5.8.6 Mannkind Dry Powder Inhaler Device Sales by Application in 2024
5.8.7 Mannkind Dry Powder Inhaler Device Sales by Geographic Area in 2024
5.8.8 Mannkind Recent Developments
5.9 Mylan
5.9.1 Mylan Company Information
5.9.2 Mylan Description, Business Overview
5.9.3 Mylan Dry Powder Inhaler Device Products Offered
5.9.4 Mylan Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Mylan Dry Powder Inhaler Device Sales by Product in 2024
5.9.6 Mylan Dry Powder Inhaler Device Sales by Application in 2024
5.9.7 Mylan Dry Powder Inhaler Device Sales by Geographic Area in 2024
5.9.8 Mylan Recent Developments
5.10 Novartis
5.10.1 Novartis Company Information
5.10.2 Novartis Description, Business Overview
5.10.3 Novartis Dry Powder Inhaler Device Products Offered
5.10.4 Novartis Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Novartis Dry Powder Inhaler Device Sales by Product in 2024
5.10.6 Novartis Dry Powder Inhaler Device Sales by Application in 2024
5.10.7 Novartis Dry Powder Inhaler Device Sales by Geographic Area in 2024
5.10.8 Novartis Recent Developments
5.11 Schering/Merck
5.11.1 Schering/Merck Company Information
5.11.2 Schering/Merck Description, Business Overview
5.11.3 Schering/Merck Dry Powder Inhaler Device Products Offered
5.11.4 Schering/Merck Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Schering/Merck Dry Powder Inhaler Device Sales by Product in 2024
5.11.6 Schering/Merck Dry Powder Inhaler Device Sales by Application in 2024
5.11.7 Schering/Merck Dry Powder Inhaler Device Sales by Geographic Area in 2024
5.11.8 Schering/Merck Recent Developments
5.12 Teva
5.12.1 Teva Company Information
5.12.2 Teva Description, Business Overview
5.12.3 Teva Dry Powder Inhaler Device Products Offered
5.12.4 Teva Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Teva Dry Powder Inhaler Device Sales by Product in 2024
5.12.6 Teva Dry Powder Inhaler Device Sales by Application in 2024
5.12.7 Teva Dry Powder Inhaler Device Sales by Geographic Area in 2024
5.12.8 Teva Recent Developments
5.13 Vectura
5.13.1 Vectura Company Information
5.13.2 Vectura Description, Business Overview
5.13.3 Vectura Dry Powder Inhaler Device Products Offered
5.13.4 Vectura Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Vectura Dry Powder Inhaler Device Sales by Product in 2024
5.13.6 Vectura Dry Powder Inhaler Device Sales by Application in 2024
5.13.7 Vectura Dry Powder Inhaler Device Sales by Geographic Area in 2024
5.13.8 Vectura Recent Developments
6 North America
6.1 North America Dry Powder Inhaler Device Market Size YoY Growth 2020-2031
6.2 North America Dry Powder Inhaler Device Market Facts & Figures by Country
6.2.1 North America Dry Powder Inhaler Device Sales by Country (2020-2031)
6.2.2 North America Dry Powder Inhaler Device Revenue by Country (2020-2031)
6.3 North America Dry Powder Inhaler Device Sales by Type (2020-2025)
6.4 North America Dry Powder Inhaler Device Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Dry Powder Inhaler Device Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Dry Powder Inhaler Device Market Facts & Figures by Region
7.2.1 Asia-Pacific Dry Powder Inhaler Device Sales by Region (2020-2031)
7.2.2 Asia-Pacific Dry Powder Inhaler Device Revenue by Region (2020-2031)
7.3 Asia-Pacific Dry Powder Inhaler Device Sales by Type (2020-2025)
7.4 Asia-Pacific Dry Powder Inhaler Device Sales by Application (2020-2025)
8 Europe
8.1 Europe Dry Powder Inhaler Device Market Size YoY Growth 2020-2031
8.2 Europe Dry Powder Inhaler Device Market Facts & Figures by Country
8.2.1 Europe Dry Powder Inhaler Device Sales by Country (2020-2031)
8.2.2 Europe Dry Powder Inhaler Device Revenue by Country (2020-2031)
8.3 Europe Dry Powder Inhaler Device Sales by Type (2020-2025)
8.4 Europe Dry Powder Inhaler Device Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Dry Powder Inhaler Device Market Size YoY Growth 2020-2031
9.2 Latin America Dry Powder Inhaler Device Market Facts & Figures by Country
9.2.1 Latin America Dry Powder Inhaler Device Sales by Country (2020-2031)
9.2.2 Latin America Dry Powder Inhaler Device Revenue by Country (2020-2031)
9.3 Latin America Dry Powder Inhaler Device Sales by Type (2020-2025)
9.4 Latin America Dry Powder Inhaler Device Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Dry Powder Inhaler Device Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Dry Powder Inhaler Device Market Facts & Figures by Country
10.2.1 Middle East and Africa Dry Powder Inhaler Device Sales by Country (2020-2031)
10.2.2 Middle East and Africa Dry Powder Inhaler Device Revenue by Country (2020-2031)
10.3 Middle East and Africa Dry Powder Inhaler Device Sales by Type (2020-2025)
10.4 Middle East and Africa Dry Powder Inhaler Device Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Dry Powder Inhaler Device Supply Chain Analysis
11.2 Dry Powder Inhaler Device Key Raw Materials and Upstream Suppliers
11.3 Dry Powder Inhaler Device Clients Analysis
11.4 Dry Powder Inhaler Device Sales Channel and Sales Model Analysis
11.4.1 Dry Powder Inhaler Device Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Dry Powder Inhaler Device Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Dry Powder Inhaler Device Distributors
12 Dry Powder Inhaler Device Market Dynamics
12.1 Dry Powder Inhaler Device Industry Trends
12.2 Dry Powder Inhaler Device Market Drivers
12.3 Dry Powder Inhaler Device Market Challenges
12.4 Dry Powder Inhaler Device Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Boehringer Ingelheim
Chiesi
Cipla Ltd
3M
Hovione
Mannkind
Novartis
Schering/Merck
TEVA
Vectura
GlaxoSmithKline
GlaxoSmithKline PLC
Astrazeneca plc
Mylan NV
List of Tables
 Table 1. Global Dry Powder Inhaler Device Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Dry Powder Inhaler Device Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Dry Powder Inhaler Device Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Dry Powder Inhaler Device Sales by Region (2020-2025) & (K Units)
 Table 5. Global Dry Powder Inhaler Device Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global Dry Powder Inhaler Device Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Dry Powder Inhaler Device Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Dry Powder Inhaler Device Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global Dry Powder Inhaler Device Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global Dry Powder Inhaler Device Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Dry Powder Inhaler Device Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Dry Powder Inhaler Device Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global Dry Powder Inhaler Device Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global Dry Powder Inhaler Device Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Dry Powder Inhaler Device Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Dry Powder Inhaler Device Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global Dry Powder Inhaler Device Sales Share by Manufacturer (2020-2025)
 Table 18. Dry Powder Inhaler Device Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Dry Powder Inhaler Device Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Dry Powder Inhaler Device Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top Dry Powder Inhaler Device Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Dry Powder Inhaler Device Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Dry Powder Inhaler Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Powder Inhaler Device as of 2024)
 Table 24. Dry Powder Inhaler Device Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Dry Powder Inhaler Device Market
 Table 26. Manufacturers Dry Powder Inhaler Device Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. GlaxoSmithKline Company Information
 Table 29. GlaxoSmithKline Description and Business Overview
 Table 30. GlaxoSmithKline Dry Powder Inhaler Device Product
 Table 31. GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. GlaxoSmithKline Sales Proportion of Dry Powder Inhaler Device by Product in 2024
 Table 33. GlaxoSmithKline Sales Proportion of Dry Powder Inhaler Device by Application in 2024
 Table 34. GlaxoSmithKline Sales Proportion of Dry Powder Inhaler Device by Geographic Area in 2024
 Table 35. GlaxoSmithKline Recent Developments
 Table 36. AstraZeneca Company Information
 Table 37. AstraZeneca Description and Business Overview
 Table 38. AstraZeneca Dry Powder Inhaler Device Product
 Table 39. AstraZeneca Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. AstraZeneca Sales Proportion of Dry Powder Inhaler Device by Product in 2024
 Table 41. AstraZeneca Sales Proportion of Dry Powder Inhaler Device by Application in 2024
 Table 42. AstraZeneca Sales Proportion of Dry Powder Inhaler Device by Geographic Area in 2024
 Table 43. AstraZeneca Recent Developments
 Table 44. Boehringer Ingelheim Company Information
 Table 45. Boehringer Ingelheim Description and Business Overview
 Table 46. Boehringer Ingelheim Dry Powder Inhaler Device Product
 Table 47. Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. Boehringer Ingelheim Sales Proportion of Dry Powder Inhaler Device by Product in 2024
 Table 49. Boehringer Ingelheim Sales Proportion of Dry Powder Inhaler Device by Application in 2024
 Table 50. Boehringer Ingelheim Sales Proportion of Dry Powder Inhaler Device by Geographic Area in 2024
 Table 51. Boehringer Ingelheim Recent Developments
 Table 52. Chiesi Company Information
 Table 53. Chiesi Description and Business Overview
 Table 54. Chiesi Dry Powder Inhaler Device Product
 Table 55. Chiesi Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. Chiesi Sales Proportion of Dry Powder Inhaler Device by Product in 2024
 Table 57. Chiesi Sales Proportion of Dry Powder Inhaler Device by Application in 2024
 Table 58. Chiesi Sales Proportion of Dry Powder Inhaler Device by Geographic Area in 2024
 Table 59. Chiesi Recent Developments
 Table 60. Cipla Company Information
 Table 61. Cipla Description and Business Overview
 Table 62. Cipla Dry Powder Inhaler Device Product
 Table 63. Cipla Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Cipla Sales Proportion of Dry Powder Inhaler Device by Product in 2024
 Table 65. Cipla Sales Proportion of Dry Powder Inhaler Device by Application in 2024
 Table 66. Cipla Sales Proportion of Dry Powder Inhaler Device by Geographic Area in 2024
 Table 67. Cipla Recent Developments
 Table 68. 3M Company Information
 Table 69. 3M Description and Business Overview
 Table 70. 3M Dry Powder Inhaler Device Product
 Table 71. 3M Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. 3M Sales Proportion of Dry Powder Inhaler Device by Product in 2024
 Table 73. 3M Sales Proportion of Dry Powder Inhaler Device by Application in 2024
 Table 74. 3M Sales Proportion of Dry Powder Inhaler Device by Geographic Area in 2024
 Table 75. 3M Recent Developments
 Table 76. Hovione Company Information
 Table 77. Hovione Description and Business Overview
 Table 78. Hovione Dry Powder Inhaler Device Product
 Table 79. Hovione Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. Hovione Sales Proportion of Dry Powder Inhaler Device by Product in 2024
 Table 81. Hovione Sales Proportion of Dry Powder Inhaler Device by Application in 2024
 Table 82. Hovione Sales Proportion of Dry Powder Inhaler Device by Geographic Area in 2024
 Table 83. Hovione Recent Developments
 Table 84. Mannkind Company Information
 Table 85. Mannkind Description and Business Overview
 Table 86. Mannkind Dry Powder Inhaler Device Product
 Table 87. Mannkind Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Mannkind Sales Proportion of Dry Powder Inhaler Device by Product in 2024
 Table 89. Mannkind Sales Proportion of Dry Powder Inhaler Device by Application in 2024
 Table 90. Mannkind Sales Proportion of Dry Powder Inhaler Device by Geographic Area in 2024
 Table 91. Mannkind Recent Developments
 Table 92. Mylan Company Information
 Table 93. Mylan Description and Business Overview
 Table 94. Mylan Dry Powder Inhaler Device Product
 Table 95. Mylan Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 96. Mylan Sales Proportion of Dry Powder Inhaler Device by Product in 2024
 Table 97. Mylan Sales Proportion of Dry Powder Inhaler Device by Application in 2024
 Table 98. Mylan Sales Proportion of Dry Powder Inhaler Device by Geographic Area in 2024
 Table 99. Mylan Recent Developments
 Table 100. Novartis Company Information
 Table 101. Novartis Description and Business Overview
 Table 102. Novartis Dry Powder Inhaler Device Product
 Table 103. Novartis Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 104. Novartis Sales Proportion of Dry Powder Inhaler Device by Product in 2024
 Table 105. Novartis Sales Proportion of Dry Powder Inhaler Device by Application in 2024
 Table 106. Novartis Sales Proportion of Dry Powder Inhaler Device by Geographic Area in 2024
 Table 107. Novartis Recent Developments
 Table 108. Schering/Merck Company Information
 Table 109. Schering/Merck Description and Business Overview
 Table 110. Schering/Merck Dry Powder Inhaler Device Product
 Table 111. Schering/Merck Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 112. Schering/Merck Sales Proportion of Dry Powder Inhaler Device by Product in 2024
 Table 113. Schering/Merck Sales Proportion of Dry Powder Inhaler Device by Application in 2024
 Table 114. Schering/Merck Sales Proportion of Dry Powder Inhaler Device by Geographic Area in 2024
 Table 115. Schering/Merck Recent Developments
 Table 116. Teva Company Information
 Table 117. Teva Description and Business Overview
 Table 118. Teva Dry Powder Inhaler Device Product
 Table 119. Teva Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 120. Teva Sales Proportion of Dry Powder Inhaler Device by Product in 2024
 Table 121. Teva Sales Proportion of Dry Powder Inhaler Device by Application in 2024
 Table 122. Teva Sales Proportion of Dry Powder Inhaler Device by Geographic Area in 2024
 Table 123. Teva Recent Developments
 Table 124. Vectura Company Information
 Table 125. Vectura Description and Business Overview
 Table 126. Vectura Dry Powder Inhaler Device Product
 Table 127. Vectura Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Vectura Sales Proportion of Dry Powder Inhaler Device by Product in 2024
 Table 129. Vectura Sales Proportion of Dry Powder Inhaler Device by Application in 2024
 Table 130. Vectura Sales Proportion of Dry Powder Inhaler Device by Geographic Area in 2024
 Table 131. Vectura Recent Developments
 Table 132. North America Dry Powder Inhaler Device Sales by Country (2020-2025) & (K Units)
 Table 133. North America Dry Powder Inhaler Device Sales by Country (2026-2031) & (K Units)
 Table 134. North America Dry Powder Inhaler Device Revenue by Country (2020-2025) & (US$ Million)
 Table 135. North America Dry Powder Inhaler Device Revenue by Country (2026-2031) & (US$ Million)
 Table 136. North America Dry Powder Inhaler Device Sales by Type (2020-2025) & (K Units)
 Table 137. North America Dry Powder Inhaler Device Sales by Application (2020-2025) & (K Units)
 Table 138. Asia-Pacific Dry Powder Inhaler Device Sales by Region (2020-2025) & (K Units)
 Table 139. Asia-Pacific Dry Powder Inhaler Device Sales by Region (2026-2031) & (K Units)
 Table 140. Asia-Pacific Dry Powder Inhaler Device Revenue by Region (2020-2025) & (US$ Million)
 Table 141. Asia-Pacific Dry Powder Inhaler Device Revenue by Region (2026-2031) & (US$ Million)
 Table 142. Asia-Pacific Dry Powder Inhaler Device Sales by Type (2020-2025) & (K Units)
 Table 143. Asia-Pacific Dry Powder Inhaler Device Sales by Application (2020-2025) & (K Units)
 Table 144. Europe Dry Powder Inhaler Device Sales by Country (2020-2025) & (K Units)
 Table 145. Europe Dry Powder Inhaler Device Sales by Country (2026-2031) & (K Units)
 Table 146. Europe Dry Powder Inhaler Device Revenue by Country (2020-2025) & (US$ Million)
 Table 147. Europe Dry Powder Inhaler Device Revenue by Country (2026-2031) & (US$ Million)
 Table 148. Europe Dry Powder Inhaler Device Sales by Type (2020-2025) & (K Units)
 Table 149. Europe Dry Powder Inhaler Device Sales by Application (2020-2025) & (K Units)
 Table 150. Latin America Dry Powder Inhaler Device Sales by Country (2020-2025) & (K Units)
 Table 151. Latin America Dry Powder Inhaler Device Sales by Country (2026-2031) & (K Units)
 Table 152. Latin America Dry Powder Inhaler Device Revenue by Country (2020-2025) & (US$ Million)
 Table 153. Latin America Dry Powder Inhaler Device Revenue by Country (2026-2031) & (US$ Million)
 Table 154. Latin America Dry Powder Inhaler Device Sales by Type (2020-2025) & (K Units)
 Table 155. Latin America Dry Powder Inhaler Device Sales by Application (2020-2025) & (K Units)
 Table 156. Middle East and Africa Dry Powder Inhaler Device Sales by Country (2020-2025) & (K Units)
 Table 157. Middle East and Africa Dry Powder Inhaler Device Sales by Country (2026-2031) & (K Units)
 Table 158. Middle East and Africa Dry Powder Inhaler Device Revenue by Country (2020-2025) & (US$ Million)
 Table 159. Middle East and Africa Dry Powder Inhaler Device Revenue by Country (2026-2031) & (US$ Million)
 Table 160. Middle East and Africa Dry Powder Inhaler Device Sales by Type (2020-2025) & (K Units)
 Table 161. Middle East and Africa Dry Powder Inhaler Device Sales by Application (2020-2025) & (K Units)
 Table 162. Dry Powder Inhaler Device Key Raw Materials, Industry Status and Trend
 Table 163. Dry Powder Inhaler Device Key Raw Materials and Upstream Suppliers
 Table 164. Dry Powder Inhaler Device Clients Status and Trend
 Table 165. Dry Powder Inhaler Device Typical Clients
 Table 166. Dry Powder Inhaler Device Distributors
 Table 167. Dry Powder Inhaler Device Market Trends
 Table 168. Dry Powder Inhaler Device Market Drivers
 Table 169. Dry Powder Inhaler Device Market Challenges
 Table 170. Dry Powder Inhaler Device Market Restraints
 Table 171. Research Programs/Design for This Report
 Table 172. Key Data Information from Secondary Sources
 Table 173. Key Data Information from Primary Sources
 Table 174. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Dry Powder Inhaler Device Product Picture
 Figure 2. Global Dry Powder Inhaler Device Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Dry Powder Inhaler Device Sales Market Share by Type in 2024 & 2031
 Figure 4. Single Dose Product Picture
 Figure 5. Multi Dose Product Picture
 Figure 6. Global Dry Powder Inhaler Device Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Dry Powder Inhaler Device Sales Market Share by Application in 2024 & 2031
 Figure 8. Asthma
 Figure 9. COPD
 Figure 10. Others
 Figure 11. Dry Powder Inhaler Device Report Years Considered
 Figure 12. Global Dry Powder Inhaler Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Dry Powder Inhaler Device Market Size 2020-2031 (US$ Million)
 Figure 14. Global Dry Powder Inhaler Device Sales 2020-2031 (K Units)
 Figure 15. Global Dry Powder Inhaler Device Sales Market Share Forecast by Region (2020-2031)
 Figure 16. Global Dry Powder Inhaler Device Revenue Market Share by Region (2020-2031)
 Figure 17. Global Dry Powder Inhaler Device Sales Market Share Forecast by Type (2020-2031)
 Figure 18. Global Dry Powder Inhaler Device Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Dry Powder Inhaler Device Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 20. Global Dry Powder Inhaler Device Sales Market Share Forecast by Application (2020-2031)
 Figure 21. Global Dry Powder Inhaler Device Revenue Market Share Forecast by Application (2020-2031)
 Figure 22. Dry Powder Inhaler Device Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 23. Single Dose of Dry Powder Inhaler Device Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Multi Dose of Dry Powder Inhaler Device Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Global Dry Powder Inhaler Device Sales Share by Manufacturer in 2024
 Figure 26. Dry Powder Inhaler Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 27. Single Dose Market Sales Proportion by Manufacturer in 2024
 Figure 28. Multi Dose Market Sales Proportion by Manufacturer in 2024
 Figure 29. North America Dry Powder Inhaler Device Revenue 2020-2031 (US$ Million)
 Figure 30. North America Dry Powder Inhaler Device Sales Market Share by Type (2020-2025)
 Figure 31. North America Dry Powder Inhaler Device Sales Market Share by Application (2020-2025)
 Figure 32. Asia-Pacific Dry Powder Inhaler Device Revenue 2020-2031 (US$ Million)
 Figure 33. Asia-Pacific Dry Powder Inhaler Device Sales Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Dry Powder Inhaler Device Revenue Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific Dry Powder Inhaler Device Sales Market Share by Type (2020-2025)
 Figure 36. Asia-Pacific Dry Powder Inhaler Device Sales Market Share by Application (2020-2025)
 Figure 37. Europe Dry Powder Inhaler Device Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Europe Dry Powder Inhaler Device Sales Market Share by Country (2020-2031)
 Figure 39. Europe Dry Powder Inhaler Device Revenue Market Share by Country (2020-2031)
 Figure 40. Europe Dry Powder Inhaler Device Sales Market Share by Type (2020-2025)
 Figure 41. Europe Dry Powder Inhaler Device Sales Market Share by Application (2020-2025)
 Figure 42. Latin America Dry Powder Inhaler Device Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 43. Latin America Dry Powder Inhaler Device Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Dry Powder Inhaler Device Revenue Market Share by Country (2020-2025)
 Figure 45. Latin America Dry Powder Inhaler Device Sales Market Share by Type (2020-2025)
 Figure 46. Latin America Dry Powder Inhaler Device Sales Market Share by Application (2020-2025)
 Figure 47. Middle East and Africa Dry Powder Inhaler Device Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 48. Middle East and Africa Dry Powder Inhaler Device Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Dry Powder Inhaler Device Revenue Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Dry Powder Inhaler Device Sales Market Share by Type (2020-2025)
 Figure 51. Middle East and Africa Dry Powder Inhaler Device Sales Market Share by Application (2020-2025)
 Figure 52. Dry Powder Inhaler Device Supply Chain (Upstream and Downstream Market)
 Figure 53. Global Production Market Share of Dry Powder Inhaler Device Raw Materials by Region in 2024
 Figure 54. Dry Powder Inhaler Device Distribution Channels
 Figure 55. Global Dry Powder Inhaler Device Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 56. Global Dry Powder Inhaler Device Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global COPD and Asthma Drug Devices Market Insights Forecast to 2030
Global Multi Dose Dry Powder Inhaler Device Market Research Report 2025
Global Dry Powder Inhalation Device Market Research Report 2024
Global Single Dose Dry Powder Inhaler Device Market Research Report 2025
Global Dry Powder Inhalation Medication Market Research Report 2024
Global Adult Dry Powder Inhalers Market Research Report 2024
Global Children Dry Powder Inhalers Market Research Report 2024
Global Dry Powder Inhalation Capsules Market Research Report 2024
Global DPI Capsules Packaging Market Research Report 2025
Global Inhaler Devices for Respiratory Medicines Market Research Report 2024
Global Inhalation Drug Delivery Devices Market Research Report 2024
Global Inhaler Devices Market Insights Forecast to 2030
Global Breath actuated Inhaler Market Research Report 2025
Global Dry Powder Inhalation Delivery System Market Research Report 2024
Global Mannitol DPI Market Research Report 2024
Air Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Asthma Inhalation Formulation Market Research Report 2024
Global Dry Powder Inhalation Excipients Market Research Report 2024
Global Corticosteroids Inhalation Formulation Market Research Report 2024
Drug Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions